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Abstract
Background: Symptom management for persons living with HIV (PLHIV) or AIDS is an important
part of care management. Limited information about symptom prevalence exists about HIV infected
persons in South Africa, in particular in the context of antiretroviral treatment (ART). The aim of
this study was to assess HIV symptoms and demographic, social and disease variables of people
living with HIV in South Africa.
Methods: In 2007 607 PLHIV, sampled by all districts in the Eastern Cape Province and recruited
through convenience sampling, were interviewed by PLHIV at health facilities, key informants in the
community and support groups.
Results: Two-thirds of the PLHIV (66%) classified themselves with being given an AIDS (advanced
stage of HIV) diagnosis, 48% were currently on ART, 35% were currently on a disability grant for
HIV/AIDS and for 13% the disability grant had been stopped. Participants reported that on the day
of the interview, they were experiencing an average of 26.1 symptoms out of a possible 64. In a
regression model with demographic and social variables, higher HIV symptom levels were
associated with lower educational levels, higher age, urban residence and not on a disability grant,
lack of enough food and having a health insurance, and in a regression model with demographic,
social and disease variables only being on ART, lack of enough food and having a health insurance
were associated with HIV symptoms.
Conclusion: Symptom assessment provides information that may be valuable in evaluating AIDS
treatment regimens and defining strategies to improve quality of life. Because of the high levels of
symptoms reported, the results imply an urgent need for effective health care, home- and
community-based as well as self-care symptom management to help patients and their families
manage and control AIDS symptoms.
Background
HIV and AIDS is one of the main challenges facing South
Africa today. Of approximately 39.5 million people living
with HIV worldwide in 2006, more than 63% were esti-
mated to be from sub-Saharan Africa [1]. About 5.54 mil-
lion people were estimated to be living with HIV in South
Africa in 2005, with 18.8% of the adult population (aged
15–49) and about 12% of the general population
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infected. Women are disproportionately affected,
accounting for approximately 55% of HIV-positive people
in South Africa [2]. Women in the age group 25–29 are the
worst affected, with HIV prevalence among them as high
as 40%, while among men peak prevalence occurs in older
age groups [2].
Although prevention still remains a top public health pri-
ority, the country has also recently (2003) instituted
antiretroviral therapies (ART) in the public health sector.
While AIDS still remains as the top cause of mortality for
the country, the availability of ART means that HIV as a
disease will likely be transformed from a high mortality
acute infectious disease to a chronic disease. Persons with
HIV and AIDS will continue to live longer, and will con-
tinue to pursue normal activities of daily living such as
eating, drinking, recreation, and procreation. It is esti-
mated that in the Eastern Cape Province of South Africa
21 294 Persons Living with HIV adults and 1 220 paediat-
rics were on ARV therapy in 2006 [3].
Wilson and Cleary [4] described a symptom as a person's
perception of an abnormal physical, emotional, or cogni-
tive state. Symptoms are perceived indicators of change in
normal functioning as experienced by the person [5]. Per-
sons infected with HIV report myriad symptoms that indi-
cate disease progression. For example, in a study of 134
persons with HIV/AIDS in Taiwan, Tsai, Hsiung and
Holzemer [6] reported that the following symptoms were
frequently described: nausea (40.3%), pain (24.6%), anx-
iety (21.6%), vomiting (16.4%), diarrhoea (14.9%), fear
(14.2%), and lack of appetite (10.4%). Fantoni et al. [7]
found that the most frequent symptoms of the 1,128 HIV-
infected persons they surveyed in Italy were fatigue
(65%), anorexia (34%), cough (32%), pain (29%), and
fever (29%). Mathews et al. [8] reported on the symptoms
of a national sample of more than 4,000 HIV/AIDS outpa-
tients in the United States: fever/night sweats (51.3%),
diarrhoea (51%), nausea/anorexia (49.8%), dysesthesias
(48.9%), and severe headache (39.3%). Karus et al. [9]
found in their study of ill HIV patients (≥ 95% AIDS) in
Alabama (n = 47), Baltimore (n = 91), and New York City
(n = 117) that on average, patients reported 10.9 (SD =
7.6) to 12.7 (SD = 6.2) symptoms.
Makoae et al. [10] studied the symptom experience of 743
people living with HIV/AIDS in four countries in South-
ern Africa (Botswana, Lesotho, South Africa, Swaziland)
in 2002 using the 64-item Revised Sign and Symptom
Checklist for Persons with HIV Disease. Results indicate
mostly unavailable ARV treatment, high levels of HIV
symptoms and a strong correlation between the frequency
of reported symptoms and their intensity. Participants
who reported having enough money for daily expenses
also reported significantly fewer symptoms. There were no
significant differences in symptom frequency between
men and women or by location of residence.
There is a paucity of more recent symptom prevalence
data about HIV infected persons in South Africa, in partic-
ular in the context of ART. The aim of this study was to
assess HIV symptoms and demographic, social and dis-
ease variables of people living with HIV in South Africa.




The sample included 607 PLHIV sampled from all dis-
tricts in the Eastern Cape Province: Amathole (81,
13.3%), Cacadu (83, 13.7%), Chris Hani (120, 19.8%),
Nelson Mandela (80, 13.2%), OR Tambo (120, 19.8%),
Alfred Nzo (82, 13.5%) and Ukhalamba (41, 6.8%). They
were recruited through convenience sampling by other
PLHIV at health facilities (42.0%), key informants in the
community (44.1%) and support groups (13.9%). Fifteen
locally based PLHIV (males and females) with a matric
qualification were appointed and trained as data collec-
tors to conduct face-to-face interviews in the districts. The
15 interviewers were asked to recruit respondents from
their own local environment. Those interviewers who
worked in a clinic or who were a member of a support
group at a clinic consecutively approached PLHIV known
to them at the different clinic sites. In case of recruitment
through key informants, the interviewers contacted some-
one in their community who was well known to them.
Also, the interviewers could recruit from their own sup-
port group in the community. The criteria for inclusion
were PLHIV who were at least 18 years old and who were
able to respond to an interviewer-administered question-
naire [11]. Informed consent was obtained from partici-
pants. The study was approved by the Human Sciences
Research Council ethics committee and the Eastern Cape
health department and conducted in 2007.
Assessment measures
a) Demographic, social and health status characteristics
Information was gathered regarding participants' sex, age,
race, years of education completed, residential area, med-
ical aid status, degree of having had food, disability grant
status, what month and year they tested HIV seropositive,
whether they had been diagnosed with an AIDS case-
defining condition, if they are currently taking antiretrovi-
ral medications, use of traditional medicine for HIV, self-
reported CD4 cell counts, and frequency of hospitaliza-
tion in the past three months.BMC Health Services Research 2008, 8:271 http://www.biomedcentral.com/1472-6963/8/271
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b) The Revised Sign and Symptom Checklist for Persons with HIV 
Disease (SSC-HIVrev)
The SSC-HIVrev is a 72-item checklist of HIV/AIDS-spe-
cific physical and psychological symptoms and includes
eight gynaecological problems not relevant to men [12].
Therefore the analysis was done on the 64 physical and
psychological symptoms. The symptom-related survey
items are scored using the following scale: 0 = not checked
(not present today), 1 = mild, 2 = moderate, 3 = severe.
Calculations included the total number of symptoms
checked as present today (with a range of 0–64) and the
total symptom intensity is a weighting of symptoms
checked by the 1-to-3 rating of mild, moderate, or severe
[12]. Validity and reliability of the instrument have previ-
ously been reported for a U.S. sample [12] and various
African countries including South Africa [10]. Reliability
estimates were calculated using Cronbach's alpha, which
was .94 in this sample for the 64-item checklist.
Data analysis
The data were analyzed using Statistical Package for the
Social Sciences for Windows (Version 12.0) software
(SPSS Inc, Chicago, IL). Basic statistical analyses were
undertaken, such as descriptive statistics and cross-tabula-
tions. Multiple hierarchical regression analysis with HIV
symptom intensity as the dependent variable enabled
comparison of demographic, social and disease variables
with symptom frequency.
Results
The participants (n = 607) reported that on the day of the
interview, they were experiencing an average of 26.1
symptoms (SD = 13.7) out of a possible 64, and among
women the total number of gynecological symptoms
experienced today was 2.6 (SD = 2.4) out of a possible 8.
The frequency and intensity of the reported symptoms are
presented in Table 1; headaches, fever, thirsty, fatigue,
weakness, painful joints, nausea, muscle aches, fears and
worries and dizziness were the top ten. Numbness/tin-
gling of hands/fingers, weight gain in stomach area, loose
stools and skinny arms and legs symptoms were signifi-
cantly more frequently reported by PLHIV on ART than
those not on ART, while diarrhoea, sore throat, painful
swallowing, sore/bleeding gums and sore/bleeding gums
were more frequently reported by those not on ART than
those on ART. Typical possible side effects from ART such
as rash (χ2 = .09, P > .05), nausea (χ2 = .11, P > .05) and
vomiting (χ2 = 1.21, P > .05) [13] did not differ signifi-
cantly between patients on ART and not on ART.
Table 2 shows demographic, social and health status
information and a multiple hierarchical regression analy-
sis with HIV symptom intensity as the dependent variable.
Most PLHIV (78.3%) were women, 75.6% were between
26 to 45 years old, and almost all were Black African
(96.9%). Half of the PLHIV came from rural (48%) and
another half from urban areas (52%) and at least 80
PLHIV came from each of the seven districts in Eastern
Cape except for Ukhahlamba (n = 41). Three in four
PLHIV (74%) had more than Grade 7 education, 70.5%
were never married, and the average number of own chil-
dren was 2.0 (SD = 1.7). On the question if they had gone
without enough food to eat in the past 12 months 40.6%
responded never or rarely, 47.3% sometimes and 12%
often. Two in five of the PLHIV (39%) indicated that they
had ever been on a disability grant for HIV/AIDS, 35% are
currently on a disability grant for HIV/AIDS and 13% said
that they were stopped on from receiving the disability
grant for HIV/AIDS (since they no longer fulfilled the cri-
teria). Three in five (60%) PLHIV were aware of their HIV
diagnosis within the last four years and 66% classified
themselves with being given an AIDS (advanced stage of
HIV) diagnosis, in particular in Cacadu, Chris Hani and
Alfred Nzo districts. One in three (32%) PLHIV self-
reported a CD4 count of less than 200 and 48% were cur-
rently on ART. Two in three PLHIV (63.7%) had visited a
clinic three or more times in the past three months and
17% had been at least once hospitalized in the past three
months.
The first regression identified residence in urban and
informal settlements but not sex, age and educational
level as independent predictors for HIV symptom inten-
sity. In the second regression analysis four social variables
were added, and age, lower education, urban residence,
having a health insurance, not having enough food and
being on a disability grant for HIV were identified as pre-
dictors for HIV symptom intensity. In the third regression
six disease characteristics variables were added, and only
not having enough food, being on ART and having a
health insurance were found as predictors for HIV symp-
tom intensity (see Table 2).
Discussion
This study found among a sample of PLHIV in the Eastern
Cape province of South Africa that they were extremely ill.
The sample reported a total of 64 different symptoms with
a mean of 26 symptoms per person which is much higher
than in a study of 743 men and women living with HIV/
AIDS from different Southern African countries in 2002
(17.6 symptoms per person) [10]. Participants also
reported high levels of psychological problems such as
fear or worries (rank 9), depression (sadness) (rank 13),
and anxiety (rank 23), which was similar to what was
found in the Southern African study (fear or worries (rank
4), depression (sadness) (rank 11), and anxiety (rank 29)
[10]. Hughes [14] also found that common under recog-
nized and/or under treated symptoms that may influence
the quality of life of PLHIV include fatigue, pain, anxiety/BMC Health Services Research 2008, 8:271 http://www.biomedcentral.com/1472-6963/8/271
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Table 1: Symptom rank order, frequency, percentage and mean intensity
Problem Rank Frequency Percentage Mean intensity (a)
Headaches 1. 403 79.0 2.15
Fever 2. 351 68.8 1.83
Thirsty 3. 346 67.8 2.17
Fatigue 4. 340 66.7 2.10
Weakness 5. 338 66.3 1.79
Painful joints 6. 332 65.1 2.08
Nausea 7. 307 60.2 1.74
Muscle aches 8. 302 59.2 1.95
Fear/Worries 9. 300 58.8 1.87
Dizziness 10. 293 57.5 1.89
Lack of appetite 11. 281 55.1 1.80
Abdominal pain 12. 280 54.9 2.08
Depression (sadness) 13. 279 54.7 2.00
Numbness/tingling of legs 14. 272 53.3 1.93
Coughing/problems catching breath 15. 271 53.1 1.92
Concern over weight loss 16. 270 52.9 2.38
Night sweats 17. 269 52.7 2.03
Memory loss 18. 264 51.8 2.04
Constipation 19. 261 51.2 1.99
Chills (feeling very cold) 20. 258 50.6 1.89
Rash 21. 257 50.4 1.99
Itchy skin 22. 256 50.2 1.98
Anxious 23. 252 49.4 1.80
Numbness/tingling of arms 24. 249 48.8 1.86
Numbness/tingling of feet/toes 25. 244 47.8 1.92
Numbness/tingling of hands/fingers 26. 242(b) 47.5 1.83
Swollen feet 27. 241 47.3 2.03
Dry mouth 28. 240 47.1 2.02
Shortness of breath with activity 29. 240 47.1 1.84
Blurred vision 30. 238 46.7 2.18
Burning with urination 31. 237 46.5 2.04
Difficulty concentrating 32. 235 46.1 1.91
Day sweats 33. 232 45.5 1.87
Chest pain 34. 213 41.8 1.96
Heart racing 35. 210 41.2 2.11
Wheezing 36. 209 41.0 1.84
Insomnia/can't sleep 37. 201 39.4 1.84
Weight gain in stomach area 38. 195(b) 38.2 2.22
Diarrhoea 39. 193(c) 37.8 1.83
Easy bruising 40. 188 36.9 1.82
Shortness of breath at rest 41. 173 33.9 1.87
Loose stools 42. 167(b) 32.7 1.78
Gas/bloating 43. 162 31.8 1.72
Sore throat 44. 156(c) 30.6 1.80
White spots in mouth/Thrush 45. 156 30.6 1.96
Painful swallowing 46. 142(c) 27.8 1.99
Breast pain/changes 47. 140 27.5 1.59
Vomiting 48. 134 26.3 1.71
Prominent leg veins 49. 133 26.1 1.94
Sore/bleeding gums 50. 130(c) 25.5 1.73
Rectal itching 51. 130 25.5 1.97
Swollen glands 52. 127 24.9 1.92
Skinny arms and legs 53. 126(b) 24.7 1.99
Mouth ulcers 54. 115 22.5 1.80
Flushing 55. 115 22.5 1.73
Sores or lumps on genitals 56. 113 22.2 1.85
Concern over weight gain 57. 110 21.6 1.72
Nose bleeds 58. 107 21.0 1.84
Seizures/tremors 59. 99 19.4 2.15
Nipple discharge 60. 61 12.0 1.68BMC Health Services Research 2008, 8:271 http://www.biomedcentral.com/1472-6963/8/271
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depression, and sleep disturbances. Fatigue was found to
be highly prevalent symptom, as found in a study among
men and women living with HIV/AIDS in Southern Africa
[15]. People living with HIV seek to acknowledge that
fatigue is a legitimate concern, not only by health care
professionals, but also people with whom they live. It is
imperative that health care providers who work with peo-
ple living with HIV-related fatigue consider the wider
social aspects of the person's life as well as physical symp-
toms [16].
Pain in the form of headache (79%), painful joints
(65%), muscle aches (59%), abdominal pain (55%),
chest pain (46%), and breast pain (28%) was one of the
most frequently experienced symptoms among PLHIV in
this study. Similarly, Norval [16] investigated symptoms
of AIDS patients in Soweto and found that of the 103
respondents (of which 3.9% had access to ART), 98%
experienced pain and 34% mentioned pain as the worst
overall symptom; lower limb pain was the most prevalent
pain (66%), followed by mouth pain (51%), headache
(42%), throat pain (40%) and chest pain (18%). People
living with HIV/AIDS often have multiple pains occurring
concurrently and are often neglected or poorly managed
symptom of AIDS [17]. The findings document that,
despite improved treatments for HIV/AIDS, many living
with the disease continue to experience high levels of
physical and psychological symptomatology. From a clin-
ical perspective, managing treatment for a patient with 26
symptoms is highly complex, often involving detailed
clinical assessment and review, polypharmacy, assess-
ment of drug and symptom interactions, and the potential
for compound side effects [18]. High levels of symptoma-
tology may also impact patients' ability or willingness to
adhere to various treatment regimens. In line with the
finding that higher symptoms were associated with hav-
ing been given an AIDS diagnosis, Singer et al. [19] found
that painful illnesses were reported at all stages of sys-
temic disease but were more common in the later stages of
disease and in subjects who progressed to a more
advanced stage during the study period. The prevalence of
many of these symptoms was similar to (and in some
instances worse than) that of terminally ill cancer patients
[20,21].
The study results suggest that social factors such as lower
educational levels, lack of enough food and not on a dis-
ability grant are significant determinants in the presenta-
tion of HIV-related symptoms. Similarly, Mathews et al.
[8] in a nationally representative US-based sample of HIV-
infected adults receiving medical care found that HIV
symptoms were greatest, among others, in persons with
lower educational levels and lower income. Poor nutri-
tional status is known to be reflected in signs and symp-
toms related to HIV infection. The effects of malnutrition
on the immune system are well known and include
decreases in CD4 Tcells, suppression of delayed hypersen-
sitivity, and abnormal B-cell responses [22]. Almost half
of the PLHIV (47.3%) in this study reported sometimes
and 12% reported often to have gone without enough
food to eat in the past 12 month, which was associated
with higher symptom frequency. With limited access to
adequate nutrition and intake of sufficient calories
become even more critical to stabilize symptoms and pre-
vent disease progression and early death. Nutritional
interventions can help manage symptoms, promote
response to medical treatment, slow progression of the
disease, and increase the quality of life by improving daily
functioning. Nutritional interventions should be consid-
ered alongside longer term, multisectoral interventions
that work to improve food security and living conditions.
The study reveals that HIV symptom levels were associ-
ated with not being on a disability grant. This may be
attributed to the findings that Phaswana-Mafuya and Pelt-
zer [23] reported from this sample elsewhere that PLHIV
used the grant to meet basic household and health care
needs. This is not surprising given the fact that more than
half (53.4%) of the respondents were unemployed and
looking for work, 15% felt sick or disabled and unable to
work, and only 8.4% were (full-time or part-time)
employed. The disability grant was a source of health and
welfare for respondents in the sample and this may be
true for most HIV sufferers in the Eastern Cape as the prov-
ince has the highest unemployment rate in the country
(48.5%) and 63% poverty rate – the second highest in the
country [24]. The expansion of the social safety net and
protecting poor people from vulnerability as well as
accessing the different social assistance grants by the poor
is a challenge for the country at large [23].
Regarding various disease characteristics (self-reported
AIDS diagnosis, hospitalization, CD4 cell counts, ART
and traditional medicine); only being on ART was in this
study associated with HIV symptom intensity. Surprising
Rectal discharge 61. 52 10.2 1.80
Blood in spit/sputum 62. 50 9.8 1.76
Hump on back of neck/shoulders 63. 47 9.2 1.95
Rectal bleeding 64. 46 9.0 1.95
"a" 1 (mild), 2 (moderate), 3 (severe). "b" Significantly more frequent among PLHIV on ART (P > .01), "c" Significantly more frequent among PLHIV 
not on ART (P > .01)
Table 1: Symptom rank order, frequency, percentage and mean intensity (Continued)BMC Health Services Research 2008, 8:271 http://www.biomedcentral.com/1472-6963/8/271
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Table 2: Demographic, social and health status information and predicting HIV symptom intensity from demographic, social and 
disease characteristics
Independent variables N M (SD) Regression equation
Symptom intensity 1 (adjusted R square = .08) 2 (adjusted R square = .16) 3(adjusted R square = .20)
Gender Beta Beta Beta
Male 104 24.6 (12.3) .07 .01 .02
Female 406 25.9 (13.9)
Age
< 35 years 352 24.9 (13.4) .05 .13* .07
35 years and more 253 27.7 (14.0)
Educational level
Grade 7 and less 158 30.0 (14.5) -.20 -.18** -.07
Grade 8–11 296 26.1 (13.3)
Grade 12 and above 152 22.2 (12.6)
Geolocality
1. Rural 255 22.6 (13.4) -- -- --
2. Informal settlements 
(shanty towns or squatter 
camps)
40 29.9 (13.1) .13*** .08 .14
3. Urban 212 28.3 (13.3) .20*** .19** .05
Do you have health insurance?
Yes 53 23.9 (13.6) .11* .17*
No 455 25.8 (13.3)
Often or sometimes not enough 
food in past 12 months
Yes 292 29.0 (13.5) .14* .28***
No 211 21.9 (12.8)
Disability grant for advanced HIV
Yes 213 25.5 (13.1) -.19*** -.12
No 111 31.3 (15.0)
Disability grant stopped
Yes 78 30.5 (15.2) .06 .15
No 209 25.4 (13.2)
Have you been given an AIDS 
diagnosis?
Yes 349 27.5 (13.0) -.00
No 157 21.6 (13.9)
Hospitalized in past 3 months
Yes 81 29.7 (13.7) .11
No 425 24.9 (13.5)
Most recent CD4
< 200 196 28.4 (13.4) -.12
200–350 145 26.2 (13.8)
> 350 169 23.7 (14.1)
ART
Yes 292 26.0 (13.0) .27***
No 297 26.2 (14.3)
ART
One year and more 123 25.2 (13.4) -.13
None or less than one year 109 29.2 (14.1)
Taking traditional medicine for 
HIV
Yes 40 26.2 (13.5) -.11
No 549 26.3 (15.8)
***P < .001, **P < .01, *P < .05BMC Health Services Research 2008, 8:271 http://www.biomedcentral.com/1472-6963/8/271
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was that being on ART was not associated with lower HIV
symptom levels. Similarly, Brechtl et al. [25] found that
among the various psychological and symptom distress
measures, only depression ratings (based on the Hamil-
ton Depression Rating Scale) decreased significantly after
three months of HAART. There were no significant
changes in any other symptom distress measures. Like-
wise, there was no significant decrease in the number of
symptoms endorsed on the MSAS, ratings of patients'
overall physical functioning (KPRS scores), or quality of
life as measured by the EFAT. Among patients who
reported pain, there was no significant change in the level
of pain intensity or pain-related functioning interference.
HAART regimens appear to have positive effects on CD4
count, HIV viral load, and several other measures of phys-
ical well-being in patients with advanced AIDS. However,
the benefits of HAART on pain and symptom distress, and
psychological well-being over a short period of time are
less clear. This finding certainly raises concerns regarding
the projected applicability of HAART regimens among
some patients with advanced HIV disease. Further
research is clearly necessary to better understand the ben-
efits of HAART therapy in patients with advanced HIV
infection. Vogl et al. [17] found that the number of symp-
toms was highly associated with poorer quality of life.
Contrary to the current study, they found that CD4+ T-cell
count was not associated with symptom number.
Limitations
Because non-probability sampling was used, the findings
are not generalisable to the entire population of PLHIV in
the Eastern Cape Province. Another limitation of the
study is that CD4 cell counts were assessed by self-report
data and not confirmed with clinical records. Even though
32.3% of patients reported a CD4 cell count less than 200,
the group as a whole seem to be "extremely ill"; 66.4%
self-reported to have been diagnosed with AIDS. This may
reflect the limitation in self reporting of CD4 counts and/
or AIDS diagnosis because the data fail to reflect how ill
the patients are [11].
Conclusion
Because of the high levels of symptoms reported, the
results imply an urgent need for effective health care,
home- and community-based as well as self-care symp-
tom management to help patients and their families man-
age and control AIDS symptoms [10,26,27]. Further
research is needed on symptoms related to HIV infection
itself, those related to opportunistic infections, and those
related to medications and treatments, in particular dur-
ing the course of the illness.
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